Global Patterns of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prevalence, Epidemiology, and Risk Factors

被引:0
作者
Amakye, Dominic [1 ]
Ssentongo, Paddy [2 ]
Patel, Swapnil [3 ]
Dalessio, Shannon [4 ]
Kochhar, Smriti [3 ]
Momin, Arsh [3 ]
Clarke, Kofi [4 ]
机构
[1] Piedmont Athens Reg Med Ctr, Dept Internal Med, Athens, GA USA
[2] Penn State Coll Med, Dept Med, Div Infect Dis, Hershey, PA USA
[3] Penn State Coll Med, Dept Med, Hershey, PA USA
[4] Penn State Coll Med, Dept Med, Div Gastroenterol & Hepatol, Hershey, PA USA
关键词
Clostridioides difficile infection; inflammatory bowel disease; risk factors; epidemiology; meta-analysis; HOSPITALIZED-PATIENTS; MANAGEMENT; IMPACT; DIAGNOSIS; COLONIZATION; MICROBIOME; GUIDELINES; BURDEN; UPDATE; ADULTS;
D O I
10.1093/crocol/otaf024
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Clostridioides difficile infection (CDI) is a well-recognized complication of inflammatory bowel disease (IBD) that has been associated with poor clinical outcomes. The objective of this study is to characterize the global incidence, risk factors and outcomes of CDI in patients with IBD.Methods A search of MEDLINE/PubMed, Scopus, and Cochrane Database of Systematic Reviews was conducted for studies published between January 1960, and March 2024. Random-effect models were employed to estimate the incidence of CDI in the IBD population. Risk factors and outcomes were estimated using random effects meta-regression and subgroup analysis.Results Twenty-eight articles from 11 countries on 3 continents, comprising 796, 244 patients with IBD were included. The overall CDI rate was 8.84% (95% CI, 5.91%-13.03%). The rate of CDI was slightly higher in Asia at 11% (95% CI, 6.7%-18.44%) compared to the North America (USA and Canada) at 7.85% (95% CI, 3.80%-15.51%) and Europe, where the incidence, was 7.92% (95% CI, 3.87%-15.51%). A univariable random-effects meta-regression model demonstrated that male gender (odds ratio [OR], 1.18; 95% CI, 1.00-1.40) and older age (OR, 1.06; 95% CI, 0.99-1.15, per one-year increase in age) were factors associated with higher CDI incidence in the IBD population. CDI testing by PCR compared to enzyme immunoassay was associated with higher rates of CDI (OR, 4.70; 95% CI, 01.39-15.90). No association was observed between length of hospital stay and CDI.Conclusions One in 10 patients with IBD were positive for CDI. Increasing age and male population were associated with higher risk of CDI. A systematic review and meta-analysis were performed to determine global incidence, risk factors and outcomes of Clostridioides difficile infection (CDI) in IBD patients. Findings showed a higher incidence in Asia and North America, with gender and age as risk factors.
引用
收藏
页数:12
相关论文
共 70 条
[1]   Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease [J].
Abdehagh, Mohammad ;
Azimirad, Masoumeh ;
Houri, Hamidreza ;
Nadalian, Banafsheh ;
Azimirad, Fahimeh ;
Olfatifar, Meysam ;
Shoeibi, Ome Kolsoum Nasir ;
Yadegar, Abbas ;
Shahrokh, Shabnam ;
Roshan, Mehran Mahdavi ;
Aghdaei, Hamid Asadzadeh ;
Zali, Mohammad Reza .
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[2]   Aging Dampens the Intestinal Innate Immune Response during Severe Clostridioides difficile Infection and Is Associated with Altered Cytokine Levels and Granulocyte Mobilization [J].
Abernathy-Close, Lisa ;
Dieterle, Michael G. ;
Vendrov, Kimberly C. ;
Bergin, Ingrid L. ;
Rao, Krishna ;
Young, Vincent B. .
INFECTION AND IMMUNITY, 2020, 88 (06)
[3]   Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease [J].
Ananthakrishnan, A. N. ;
McGinley, E. L. ;
Binion, D. G. .
GUT, 2008, 57 (02) :205-210
[4]   Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases [J].
Ananthakrishnan, A. N. ;
Cagan, A. ;
Gainer, V. S. ;
Cheng, S-C. ;
Cai, T. ;
Szolovits, P. ;
Shaw, S. Y. ;
Churchill, S. ;
Karlson, E. W. ;
Murphy, S. N. ;
Kohane, I. ;
Liao, K. P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) :1136-1142
[5]   Genetic risk factors for Clostridium difficile infection in ulcerative colitis [J].
Ananthakrishnan, A. N. ;
Oxford, E. C. ;
Nguyen, D. D. ;
Sauk, J. ;
Yajnik, V. ;
Xavier, R. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (05) :522-530
[6]   Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis [J].
Anderson, Alyce ;
Click, Benjamin ;
Ramos-Rivers, Claudia ;
Cheng, Debbie ;
Babichenko, Dmitriy ;
Koutroubakis, Ioannis E. ;
Hashash, Jana G. ;
Schwartz, Marc ;
Swoger, Jason ;
Barrie, Arthur M., III ;
Dunn, Michael A. ;
Regueiro, Miguel ;
Binion, David G. .
INFLAMMATORY BOWEL DISEASES, 2017, 23 (12) :2180-2188
[7]   Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management [J].
Bai, Mei ;
Guo, Hong ;
Zheng, Xiao-Yao .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
[8]   Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis [J].
Balram, Bhairavi ;
Battat, Robert ;
Al-Khoury, Alex ;
D'Aoust, Julie ;
Afif, Waqqas ;
Bitton, Alain ;
Lakatos, Peter L. ;
Bessissow, Talat .
JOURNAL OF CROHNS & COLITIS, 2019, 13 (01) :27-38
[9]   OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS [J].
BEGG, CB ;
MAZUMDAR, M .
BIOMETRICS, 1994, 50 (04) :1088-1101
[10]   American Journal of Gastroenterology Lecture: Intestinal Microbiota and the Role of Fecal Microbiota Transplant (FMT) in Treatment of C. difficile Infection [J].
Brandt, Lawrence J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (02) :177-185